Passionate about innovation, I have dedicated my professional life to find disruptive ways to prevent cancer, making an impact on people´s lives through early diagnostics. CEO of Amadix, the first Global Winner of South Summit in the healthcare field. It is a disruptive biotech company in the liquid biopsy space, focused on early cancer detection in blood, before the symptoms appear, to extend people´s lives. We develop technologies to detect colon, pancreatic and lung cancer in blood, a few years before the tumor appears, in healthy individuals with no symptoms. Extensive pharmaceutical, biotechnology, and public/private health-sector knowledge. I like teaching, to inspire curiosity in the students so they will be the best they can be. I am a Board Member of different Business Schools and Universities, and participate in programs for mentoring and connecting innovators, researchers and entrepreneurs. Included in the “Women Leaders in Entrepreneurship and Innovation in Spain” list, by the Spanish Goverment. Board Member of Spanish Biotech Companies Association (AseBio), I lead the Precision Medicine & Molecular Diagnostics National Group. EU Women Innovator 2021 finalist by the European Comission, and selected by FORBES as one of the 22 leaders to drive change in 2022. Enthusiastic, curious and persistent to change things.
CEO at Amadix
Master of Business Administration - MBA